Atrial Fibrillation (AF) and Electrocardiogram (EKG) Interpretation Project ECHO

NCT05890274 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 70

Last updated 2026-04-27

No results posted yet for this study

Summary

The goal of this study is to determine the effectiveness of a direct-to-provider virtual education program ("AF and EKG Interpretation Project ECHO") for primary care providers who manage patients with atrial fibrillation (AF). The main questions this study aims to answer are:

1. Will participants have improvement in knowledge and confidence in managing patients with atrial fibrillation after program completion?
2. Will quality and performance metrics improve at the patient level for program participants?

Participants will be asked to:

* Participate in 12 hours of virtual education sessions over twelve weeks via Zoom.
* Complete a knowledge and confidence assessment online before the program starts and after its completion.

Conditions

Interventions

OTHER

AF and EKG Interpretation Project ECHO

The AF and EKG Interpretation Project ECHO program is delivered via Zoom videoconferencing technology and includes 12, 1-hour long sessions that involve education on best practice management of AF for primary care providers. Each session includes an EKG challenge, case presentation by a participant, didactic presentation, and time for open Q\&A. Supplementary materials are made available to all participants.

Sponsors & Collaborators

Principal Investigators

  • Anil Gehi, MD · University of North Carolina, Chapel Hill

Study Design

Allocation
NA
Purpose
OTHER
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-09-04
Primary Completion
2026-03-25
Completion
2026-03-25

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05890274 on ClinicalTrials.gov